Who is suitable for larotrectinib?

Larotrectinib is a targeted therapy drug used to treat cancers related to specific genetic abnormalities. It is mainly suitable for adult and pediatric patients with NTRK gene fusion. NTRKGene fusion is a rare but genetic abnormality that occurs in a variety of cancers, including soft tissue sarcoma, infantile fibroma, lung cancer, etc.

ApplicablePatients with NTRK gene fusion are the main recipients of larotrectinib. This gene fusion makes NTRK kinase out of normal regulation, leading to abnormal cell proliferation and survival signaling, and promoting the development of tumors. By inhibiting the activity of NTRK kinase, larotrectinib can interfere with these abnormal signaling pathways, thereby inhibiting tumor growth.

Clinical trial results show that patients carryingNTRK gene fusions have achieved remarkable results after receiving larotrectinib treatment, including tumor shrinkage, stopping progression or even complete disappearance. Therefore, patients with tumors suffering from NTRK gene fusion, especially soft tissue sarcoma and other related cases, can be considered as an applicable population.

Before using larotrectinib, it is recommended that patients undergo genetic testing to determine whether their tumors carryNTRK gene fusions to ensure the best therapeutic effect. Doctors will determine whether the patient is suitable for larotrectinib treatment based on specific genetic test results.

Larotrectinib has been launched in China and has not yet been included in medical insurance. Since it has not been launched in China for a long time, it may be difficult to purchase it in hospitals. For specific conditions, it is recommended to consult the local hospital pharmacy. In foreign markets, larotinib has two options: original drug and generic drug. Original drugs include the German version, the American version, the European version and the Hong Kong version, and the price is about 10,000 to 20,000 yuan. In comparison, generic drugs are much cheaper. There are Lao and Bangladeshi versions of generic drugs, and the price is around two to three thousand. It is worth noting that the ingredients of original drugs and generic drugs are basically the same.